Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · IEX Real-Time Price · USD
0.689
+0.033 (5.11%)
At close: May 17, 2024, 4:00 PM
0.723
+0.034 (5.00%)
After-hours: May 17, 2024, 6:03 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $51.63 million as of May 17, 2024. Its market cap has increased by 7.35% in one year.
Market Cap
51.63M
Enterprise Value
-50.84M
1-Year Change
7.35%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $51.63M, a decrease of -90.67%. That is a compound annual growth rate of -48.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 53.80M | 5.08% |
| May 16, 2024 | 51.20M | -3.40% |
| May 15, 2024 | 53.00M | -2.03% |
| May 14, 2024 | 54.10M | 1.12% |
| May 13, 2024 | 53.50M | -6.14% |
| May 10, 2024 | 57.00M | -5.94% |
| May 9, 2024 | 60.60M | -0.98% |
| May 8, 2024 | 61.20M | -0.81% |
| May 7, 2024 | 61.70M | 0.65% |
| May 6, 2024 | 61.30M | - |
| May 3, 2024 | 61.30M | -4.22% |
| May 2, 2024 | 64.00M | 9.78% |
| May 1, 2024 | 58.30M | 0.69% |
| Apr 30, 2024 | 57.90M | 4.32% |
| Apr 29, 2024 | 55.50M | -6.25% |
| Apr 26, 2024 | 59.20M | -4.36% |
| Apr 25, 2024 | 61.90M | -1.28% |
| Apr 24, 2024 | 62.70M | 0.48% |
| Apr 23, 2024 | 62.40M | 2.97% |
| Apr 22, 2024 | 60.60M | 6.69% |
| Apr 19, 2024 | 56.80M | -5.33% |
| Apr 18, 2024 | 60.00M | 0.67% |
| Apr 17, 2024 | 59.60M | -5.70% |
| Apr 16, 2024 | 63.20M | -6.65% |
| Apr 15, 2024 | 67.70M | -10.57% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Scientific | 54.42M |
| Rockwell Medical | 54.27M |
| Cidara Therapeutics | 53.14M |
| BioLineRx | 52.97M |
| Cytosorbents | 52.41M |
| Inotiv | 50.29M |
| Dyadic International | 50.29M |
| NeueHealth | 50.01M |